Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New Appointments

15 Jan 2009 07:00

RNS Number : 6646L
Plant Health Care PLC
15 January 2009
 



15 January 2009

Plant Health Care plc

("Plant Health Care" or "the Company")

PLANT HEALTH CARE BOOSTS MANAGEMENT TEAM

Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries, announces the appointment of Greg Warren as its Chief Operating Officer, Cheryl Eberle as Managing Director of its US Horticulture & Turf Division and Daryl Nelson as Corporate Controller. 

In his capacity as COO, Greg will be responsible for all areas of Plant Health Care's agriculture operations, horticulture and turf, reclamation and technical services. 

Prior to joining Plant Health Care, Greg was Vice President and General Manager of Chemtura Corporation's North America crop protection business where he was responsible for marketing, sales, research & development and business development.

Cheryl will be replacing Michael Kubinec as the head of Plant Health Care's US Horticulture and Turf operation. Michael has been promoted to work in the area of corporate business development. 

Cheryl was most recently general manager of the Pittsburgh, Pennsylvania Shemin Nurseries. Her responsibilities at Shemin included complete P&L responsibility for branch operations as well as direct supervision over all sales and marketing activities. 

Daryl has over 15 years of financial and operational experience with a number of major companies in the Pittsburgh area including Allegheny Technologies and Calgon Carbon, and most recently Hydrogen LLC. Daryl is a CPA with strong experience in the areas of public reporting and compliance and has implemented Sarbanes Oxley initiatives at all three of these companies. Daryl has also been successfully involved in a number of operational areas including supply chain and logistics.

John Brady, chief executive of Plant Health Care, said: "In order to cope with and maintain our rapid expansion it has been necessary to further strengthen our management team. Greg and Cheryl bring a wealth of experience and an intimate knowledge of sales, marketing and distribution to the Company." 

"Daryl's wide variety of corporate experience and subsequent understanding of both the financial and operational aspects of these businesses will also be of great benefit to Plant Health Care. On behalf of the Board I would like to welcome them to the Company and wish them every success."

- ends -

For further information:

John Brady

Evolution Securities Limited

Tavistock Communications

Chief Executive

Tim Worlledge/Tim Redfern

Jeremy Carey/Simon Compton

Tel: 001 603 525 3702

Tel: 020 7071 4300

Tel: 020 7920 3150

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFMFWLSUSELF
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.